BR9708979A - Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein - Google Patents
Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a proteinInfo
- Publication number
- BR9708979A BR9708979A BR9708979A BR9708979A BR9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A
- Authority
- BR
- Brazil
- Prior art keywords
- immunogenic complex
- protein
- preparation
- same vaccine
- vaccine process
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9605692A FR2748476B1 (en) | 1996-05-07 | 1996-05-07 | IMMUNOGENIC COMPLEX, ITS USE, ITS PREPARATION METHOD AND VACCINE CONTAINING THE SAME |
| PCT/FR1997/000800 WO1997041888A1 (en) | 1996-05-07 | 1997-05-06 | Immunogenic complex, use, method of preparation thereof and vaccine containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708979A true BR9708979A (en) | 1999-08-03 |
Family
ID=9491907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708979A BR9708979A (en) | 1996-05-07 | 1997-05-06 | Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0914152A1 (en) |
| JP (1) | JP2000509707A (en) |
| CN (1) | CN1221348A (en) |
| AU (1) | AU733845B2 (en) |
| BR (1) | BR9708979A (en) |
| CA (1) | CA2254084A1 (en) |
| FR (1) | FR2748476B1 (en) |
| NZ (1) | NZ332809A (en) |
| WO (1) | WO1997041888A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2776521B1 (en) * | 1998-03-27 | 2000-12-15 | Pf Medicament | USE OF P40 ACTIVE CONJUGATES BY NASAL |
| FR2785542B1 (en) * | 1998-11-06 | 2001-02-09 | Pf Medicament | USE OF AN ENTEROMACTERY OmpA PROTEIN FOR THE SPECIFIC TARGETING OF A BIOLOGICALLY ACTIVE SUBSTANCE THAT IS ASSOCIATED WITH CELLS PRESENTING ANTIGENS SUCH AS HUMAN DENDRITIC CELLS |
| US6146902A (en) * | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| FR2789588B1 (en) * | 1999-02-17 | 2001-05-04 | Pf Medicament | USE OF AN OMPA ENTEROBACTERIA PROTEIN ASSOCIATED WITH AN ANTIGEN IN A PHARMACEUTICAL COMPOSITION FOR GENERATING OR INCREASING ANTIVIRAL, PEST CONTROL OR ANTITUMOR CYTOTOXIC RESPONSE |
| FR2789902A1 (en) * | 1999-02-24 | 2000-08-25 | Pf Medicament | Use of enterobacterial outer membrane protein as immunogenic carrier, particularly for contraceptive and anti-cancer vaccines, provides strong humoral response |
| FR2790959B1 (en) * | 1999-03-15 | 2003-06-27 | Pf Medicament | USE OF BACTERIAL MEMBRANARY FRACTIONS WITH ADJUVANT EFFECT, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
| FR2828106A1 (en) * | 2001-08-02 | 2003-02-07 | Pf Medicament | Composition containing peptide from low molecular weight outer membrane protein, useful for preparing vaccines against infections or cancer |
| JP5286089B2 (en) * | 2006-01-13 | 2013-09-11 | バクスター・インターナショナル・インコーポレイテッド | Method for purifying polysaccharides |
| CN107184972B (en) * | 2017-06-20 | 2020-12-01 | 康希诺生物股份公司 | A kind of Mycobacterium tuberculosis OS-tb oligosaccharide conjugate and its preparation method and application |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
| FR2682388B1 (en) * | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | PROCESS FOR THE PREPARATION OF AN OLIGOSIDE BY DEPOLYMERIZATION OF A POLYOSIDE DERIVED FROM A PATHOGENIC AGENT, OLIGOSIDE THUS OBTAINED AND ITS USE IN PARTICULAR AS A VACCINE AGENT. |
| US6153406A (en) * | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
| FR2718452B1 (en) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Element of immunogen, immunogenic agent, pharmaceutical composition and method of preparation. |
| FR2726472B1 (en) * | 1994-11-07 | 1997-01-31 | Pf Medicament | CARRIER WITH ADJUVANT EFFECT, IMMUNOGENIC COMPLEX CONTAINING THE SAME, PREPARATION METHOD THEREOF, NUCLEOTIDE SEQUENCE AND VACCINE |
| FR2726471B1 (en) * | 1994-11-07 | 1997-01-31 | Pf Medicament | PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES |
-
1996
- 1996-05-07 FR FR9605692A patent/FR2748476B1/en not_active Expired - Fee Related
-
1997
- 1997-05-06 JP JP9539595A patent/JP2000509707A/en active Pending
- 1997-05-06 EP EP97923139A patent/EP0914152A1/en not_active Withdrawn
- 1997-05-06 CN CN97195397A patent/CN1221348A/en active Pending
- 1997-05-06 BR BR9708979A patent/BR9708979A/en not_active Application Discontinuation
- 1997-05-06 WO PCT/FR1997/000800 patent/WO1997041888A1/en not_active Ceased
- 1997-05-06 NZ NZ332809A patent/NZ332809A/en unknown
- 1997-05-06 AU AU29019/97A patent/AU733845B2/en not_active Ceased
- 1997-05-06 CA CA002254084A patent/CA2254084A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0914152A1 (en) | 1999-05-12 |
| JP2000509707A (en) | 2000-08-02 |
| FR2748476B1 (en) | 1998-08-14 |
| NZ332809A (en) | 2000-05-26 |
| CA2254084A1 (en) | 1997-11-13 |
| WO1997041888A1 (en) | 1997-11-13 |
| AU2901997A (en) | 1997-11-26 |
| CN1221348A (en) | 1999-06-30 |
| FR2748476A1 (en) | 1997-11-14 |
| AU733845B2 (en) | 2001-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9710182A (en) | Ampoule packaging apparatus and process for making an ampoule packaging and use of an ampoule packaging | |
| FI950249A0 (en) | Surgical tips and procedures | |
| FI951468L (en) | Lipopeptide derivatives, method for their preparation and use | |
| PT1003478E (en) | AQUOSOL AQUOSOL PREPARATIONS CONTAINING BIOLOGICALLY ACTIVE MACROMOLECULES AND PROCESS FOR THE PREPARATION OF THEIR RESPIRATORS | |
| EE9900014A (en) | Erythromycins and the process for their preparation | |
| EE03778B1 (en) | Cancer vaccine and method for its preparation | |
| EE03380B1 (en) | Pharmaceutical aerosol formulation and process for its preparation | |
| FI941528A0 (en) | Method and apparatus for the preparation of light olefins | |
| FI964102L (en) | Process for the preparation of phenol and phenol derivatives | |
| FI973195L (en) | Hair extract, method for its preparation and use | |
| BR9502471A (en) | Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition | |
| FI971202L (en) | Methods for the preparation of levobupivacaine and its analogues for racemization and asymmetric transformation | |
| PT909270E (en) | METHOD FOR THE PREPARATION OF 2,4-DIHYDROXYPRIDINE AND 2,4-DIHIDROXY-3-NITROPYRIDINE | |
| EE04681B1 (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
| BR8903705A (en) | ARTIFICIAL HAIR FOR HAIR IMPLANT AND PROCESS AND PREPARATION APPARATUS FOR THE SAME | |
| BR9600149A (en) | 2- (2-N-alkoxyphenyl) -purin-6-ones 9-substituted process for its medical preparation and use | |
| PT949335E (en) | METHOD FOR PREPARING DURING THE PURIFIED DENTURE OF BONE DERIVED FACTOR | |
| AU1631188A (en) | Newcastle disease virus vaccine and method for the application thereof | |
| BR9708979A (en) | Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein | |
| EE9800075A (en) | Combined medicinal product, its use and method of its preparation | |
| AU2981395A (en) | Method of identifying and producing antigen peptides and use thereof as vaccines | |
| BR9601193A (en) | Multi-component vaccine and processes for preparing and administering the vaccine | |
| BR9706239A (en) | Process for the preparation of 3- (1-hydroxyphenyl-1-alkoxyimino-methyl) dioxazins | |
| BR9603124A (en) | Dipeptide process for preparing the same mixture and drugs | |
| FI963947L (en) | Fully dissolved bone tissue and method for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |